Literature DB >> 34127694

A machine learning approach to predict healthcare cost of breast cancer patients.

Pratyusha Rakshit1, Onintze Zaballa2, Aritz Pérez2, Elisa Gómez-Inhiesto3, Maria T Acaiturri-Ayesta3, Jose A Lozano2.   

Abstract

This paper presents a novel machine learning approach to perform an early prediction of the healthcare cost of breast cancer patients. The learning phase of our prediction method considers the following two steps: (1) in the first step, the patients are clustered taking into account the sequences of actions undergoing similar clinical activities and ensuring similar healthcare costs, and (2) a Markov chain is then learned for each group to describe the action-sequences of the patients in the cluster. A two step procedure is undertaken in the prediction phase: (1) first, the healthcare cost of a new patient's treatment is estimated based on the average healthcare cost of its k-nearest neighbors in each group, and (2) finally, an aggregate measure of the healthcare cost estimated by each group is used as the final predicted cost. Experiments undertaken reveal a mean absolute percentage error as small as 6%, even when half of the clinical records of a patient is available, substantiating the early prediction capability of the proposed method. Comparative analysis substantiates the superiority of the proposed algorithm over the state-of-the-art techniques.

Entities:  

Year:  2021        PMID: 34127694     DOI: 10.1038/s41598-021-91580-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  2 in total

1.  Why, When and How to Adjust Your P Values?

Authors:  Mohieddin Jafari; Naser Ansari-Pour
Journal:  Cell J       Date:  2018-08-01       Impact factor: 2.479

2.  Identifying common treatments from Electronic Health Records with missing information. An application to breast cancer.

Authors:  Onintze Zaballa; Aritz Pérez; Elisa Gómez Inhiesto; Teresa Acaiturri Ayesta; Jose A Lozano
Journal:  PLoS One       Date:  2020-12-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.